Aldosterone and glomerular podocyte injury

Clinical and Experimental Nephrology

Volumn 12, Issue 4, 2008, Pages 233-242

  Nagase, Miki ^a   Fujita, Toshiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Aldosterone releasing factors; Chronic kidney disease; Metabolic syndrome; Mineralocorticoid receptor activation; Oxidative stress; Proteinuria; Salt

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; AMILORIDE; ANTIOXIDANT; EPLERENONE; FUROSEMIDE; HYDRALAZINE; MINERALOCORTICOID RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM CHLORIDE; TEMPOL; THIAZIDE DIURETIC AGENT;

ADIPOCYTE; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ENZYME ACTIVATION; GLOMERULUS; HORMONE ACTION; IN VITRO STUDY; IN VIVO STUDY; INJURY; KIDNEY DISEASE; KIDNEY INJURY; METABOLIC DISORDER; NONHUMAN; OBESITY; OXIDATIVE STRESS; PATHOGENESIS; PODOCYTE; PROTEINURIA; REVIEW; SPONTANEOUSLY HYPERTENSIVE RAT; TARGET ORGAN;

ALDOSTERONE; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OXIDATIVE STRESS; PODOCYTES; PROTEINURIA; RATS;

EID: 47649085301     PISSN: 13421751     EISSN: 14377799     Source Type: Journal    
DOI: 10.1007/s10157-008-0034-9     Document Type: Review

References (110)

1. SA Simpson JF Tait A Wettstein R Neher J von Euw T Reichstein 1953 Isolierung eines neuen kristallisierten Hormons aus Nebennerien mit besonders hoher Wirksamkeit auf den Mineralsoffwechsel Experientia 9 333 5
2. JS Williams GH Williams 2003 50th anniversary of aldosterone J Clin Endocrinol Metab 88 2364 72
3. RP Lifton AG Gharavi DS Geller 2001 Molecular mechanisms of human hypertension Cell 104 545 56
4. FH Wilson S Disse-Nicodeme KA Choate K Ishikawa C Nelson-Williams I Desitter 2001 Human hypertension caused by mutations in WNK kinases Science 293 1107 12
5. TH Hostetter HN Ibrahim 2003 Aldosterone in chronic kidney and cardiac disease J Am Soc Nephrol 14 2395 401
6. R Rocha JW Funder 2002 The pathophysiology of aldosterone in the cardiovascular system Ann NY Acad Sci 970 89 100
7. PJ Fuller MJ Young 2005 Mechanisms of mineralocorticoid action Hypertension 46 1227 35
8. B Pitt F Zannad WJ Remme R Cody A Castaigne A Perez 1999 The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized aldactone evaluation study investigators N Engl J Med 341 709 17
9. B Pitt W Remme F Zannad J Neaton F Martinez B Roniker 2003 Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 348 1309 21
10. M Epstein 2006 Aldosterone blockade: an emerging strategy for abrogating progressive renal disease Am J Med 119 912 9
11. S Shibata M Nagase S Yoshida H Kawachi T Fujita 2007 Podocyte as the target for aldosterone: roles of oxidative stress and Sgk1 Hypertension 49 355 64
12. M Nagase S Shibata S Yoshida T Nagase T Gotoda T Fujita 2006 Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker Hypertension 47 1084 93
13. M Nagase S Yoshida S Shibata T Nagase T Gotoda K Ando 2006 Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors J Am Soc Nephrol 17 3438 46
14. M Nagase H Matsui S Shibata T Gotoda T Fujita 2007 Salt-induced nephropathy in obese spontaneously hypertensive rats via paradoxical activation of the mineralocorticoid receptor: role of oxidative stress Hypertension 50 877 83
15. DJ Rozansky 2006 The role of aldosterone in renal sodium transport Semin Nephrol 26 173 81
16. P Meneton J Loffing DG Warnock 2004 Sodium and potassium handling by the aldosterone-sensitive distal nephron: the pivotal role of the distal and connecting tubule Am J Physiol Renal Physiol 287 F593 601
17. MA Knepper GH Kim S Masilamani 2003 Renal tubule sodium transporter abundance profiling in rat kidney: response to aldosterone and variations in NaCl intake Ann NY Acad Sci 986 562 9
18. F Lang C Bohmer M Palmada G Seebohm N Strutz-Seebohm V Vallon 2006 (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms Physiol Rev 86 1151 78
19. J Hou HJ Speirs JR Seckl RW Brown 2002 Sgk1 gene expression in kidney and its regulation by aldosterone: spatio-temporal heterogeneity and quantitative analysis J Am Soc Nephrol 13 1190 8
20. AM Ring Q Leng J Rinehart FH Wilson KT Kahle SC Hebert 2007 An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis Proc Natl Acad Sci USA 104 4025 9
21. S Berger M Bleich W Schmid TJ Cole J Peters H Watanabe 1998 Mineralocorticoid receptor knockout mice: pathophysiology of Na+ metabolism Proc Natl Acad Sci USA 95 9424 9
22. C Ronzaud J Loffing M Bleich N Gretz HJ Grone G Schutz 2007 Impairment of sodium balance in mice deficient in renal principal cell mineralocorticoid receptor J Am Soc Nephrol 18 1679 87
23. E Hummler P Barker C Talbot Q Wang C Verdumo B Grubb 1997 A mouse model for the renal salt-wasting syndrome pseudohypoaldosteronism Proc Natl Acad Sci USA 94 11710 5
24. S Pradervand PM Barker Q Wang SA Ernst F Beermann BR Grubb 1999 Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the beta-subunit of the amiloride-sensitive epithelial sodium channel Proc Natl Acad Sci USA 96 1732 7
25. P Wulff V Vallon DY Huang H Volkl F Yu K Richter 2002 Impaired renal Na(+) retention in the sgk1-knockout mouse J Clin Invest 110 1263 8
26. M Epstein 2001 Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift J Hypertens 19 829 42
27. R Rocha AE Rudolph GE Frierdich DA Nachowiak BK Kekec EA Blomme 2002 Aldosterone induces a vascular inflammatory phenotype in the rat heart Am J Physiol Heart Circ Physiol 283 H1802 10
28. M Wehling 1997 Specific, nongenomic actions of steroid hormones Annu Rev Physiol 59 365 93
29. ER Blasi R Rocha AE Rudolph EA Blomme ML Polly EG McMahon 2003 Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats Kidney Int 63 1791 800
30. A Nishiyama L Yao Y Nagai K Miyata M Yoshizumi S Kagami 2004 Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats Hypertension 43 841 8
31. K Miyata M Rahman T Shokoji Y Nagai GX Zhang GP Sun 2005 Aldosterone stimulates reactive oxygen species production through activation of NADPH oxidase in rat mesangial cells J Am Soc Nephrol 16 2906 12
32. Y Terada T Kobayashi H Kuwana H Tanaka S Inoshita M Kuwahara 2005 Aldosterone stimulates proliferation of mesangial cells by activating mitogen-activated protein kinase 1/2, cyclin D1, and cyclin A J Am Soc Nephrol 16 2296 305
33. Y Nagai K Miyata GP Sun M Rahman S Kimura A Miyatake 2005 Aldosterone stimulates collagen gene expression and synthesis via activation of ERK1/2 in rat renal fibroblasts Hypertension 46 1039 45
34. K Ishizawa Y Izawa H Ito C Miki K Miyata Y Fujita 2005 Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation Hypertension 46 1046 52
35. Y Sun J Zhang L Lu SS Chen MT Quinn KT Weber 2002 Aldosterone-induced inflammation in the rat heart : role of oxidative stress Am J Pathol 161 1773 81
36. S Keidar M Kaplan E Pavlotzky R Coleman T Hayek S Hamoud 2004 Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone Circulation 109 2213 20
37. JA Leopold A Dam BA Maron AW Scribner R Liao DE Handy 2007 Aldosterone impairs vascular reactivity by decreasing glucose-6-phosphate dehydrogenase activity Nat Med 13 189 97
38. A Nishiyama L Yao Y Fan M Kyaw N Kataoka K Hashimoto 2005 Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability Hypertension 45 710 6
39. GP Sun M Kohno P Guo Y Nagai K Miyata YY Fan 2006 Involvements of Rho-kinase and TGF-beta pathways in aldosterone-induced renal injury J Am Soc Nephrol 17 2193 201
40. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
41. HN Ibrahim TH Hostetter 2003 Aldosterone in renal disease. Curr Opin Nephrol Hypertens 12 159 64
42. NJ Brown 2005 Aldosterone and end-organ damage Curr Opin Nephrol Hypertens 14 235 41
43. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The collaborative study group N Engl J Med 329 1456 62
44. EL Greene S Kren TH Hostetter 1996 Role of aldosterone in the remnant kidney model in the rat J Clin Invest 98 1063 8
45. R Rocha PN Chander A Zuckerman CT Stier Jr 1999 Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats Hypertension 33 232 7
46. J Ribstein G Du Cailar P Fesler A Mimran 2005 Relative glomerular hyperfiltration in primary aldosteronism J Am Soc Nephrol 16 1320 5
47. GP Rossi G Bernini G Desideri B Fabris C Ferri G Giacchetti 2006 Renal damage in primary aldosteronism: results of the PAPY Study Hypertension 48 232 8
48. WB White D Duprez R St Hillaire S Krause B Roniker J Kuse-Hamilton 2003 Effects of the selective aldosterone blocker eplerenone versus the calcium antagonist amlodipine in systolic hypertension Hypertension 41 1021 6
49. GH Williams E Burgess RE Kolloch LM Ruilope J Niegowska MS Kipnes 2004 Efficacy of eplerenone versus enalapril as monotherapy in systemic hypertension Am J Cardiol 93 990 6
50. A Sato K Hayashi M Naruse T Saruta 2003 Effectiveness of aldosterone blockade in patients with diabetic nephropathy Hypertension 41 64 8
51. SY Han CH Kim HS Kim YH Jee HK Song MH Lee 2006 Spironolactone prevents diabetic nephropathy through an anti-inflammatory mechanism in type 2 diabetic rats J Am Soc Nephrol 17 1362 72
52. KJ Schjoedt K Rossing TR Juhl F Boomsma L Tarnow P Rossing 2006 Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy Kidney Int 70 536 42
53. A Chrysostomou G Becker 2001 Spironolactone in addition to ACE inhibition to reduce proteinuria in patients with chronic renal disease N Engl J Med 345 925 6
54. M Quinkler D Zehnder KS Eardley J Lepenies AJ Howie SV Hughes 2005 Increased expression of mineralocorticoid effector mechanisms in kidney biopsies of patients with heavy proteinuria Circulation 112 1435 43
55. F Artunc K Amann O Nasir B Friedrich D Sandulache N Jahovic 2006 Blunted DOCA/high salt induced albuminuria and renal tubulointerstitial damage in gene-targeted mice lacking SGK1 J Mol Med 84 737 46
56. V Vallon DY Huang F Grahammer AW Wyatt H Osswald P Wulff 2005 SGK1 as a determinant of kidney function and salt intake in response to mineralocorticoid excess Am J Physiol Regul Integr Comp Physiol 289 R395 401
57. K Tryggvason J Patrakka J Wartiovaara 2006 Hereditary proteinuria syndromes and mechanisms of proteinuria N Engl J Med 354 1387 401
58. H Pavenstadt W Kriz M Kretzler 2003 Cell biology of the glomerular podocyte Physiol Rev 83 253 307
59. J Reiser P Mundel 2004 Danger signaling by glomerular podocytes defines a novel function of inducible B7-1 in the pathogenesis of nephrotic syndrome J Am Soc Nephrol 15 2246 8
60. M Kestila U Lenkkeri M Mannikko J Lamerdin P McCready H Putaala 1998 Positionally cloned gene for a novel glomerular protein-nephrin-is mutated in congenital nephrotic syndrome Mol Cell 1 575 82
61. NY Shih J Li V Karpitskii A Nguyen ML Dustin O Kanagawa 1999 Congenital nephrotic syndrome in mice lacking CD2-associated protein Science 286 312 5
62. N Boute O Gribouval S Roselli F Benessy H Lee A Fuchshuber 2000 NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid-resistant nephrotic syndrome Nat Genet 24 349 54
63. JM Kaplan SH Kim KN North H Rennke LA Correia HQ Tong 2000 Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis Nat Genet 24 251 6
64. ME Pagtalunan PL Miller S Jumping-Eagle RG Nelson BD Myers HG Rennke 1997 Podocyte loss and progressive glomerular injury in type II diabetes J Clin Invest 99 342 8
65. G Wolf S Chen FN Ziyadeh 2005 From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy Diabetes 54 1626 34
66. M Kretzler I Koeppen-Hagemann W Kriz 1994 Podocyte damage is a critical step in the development of glomerulosclerosis in the uninephrectomised- desoxycorticosterone hypertensive rat Virchows Arch 425 181 93
67. HM Chen ZH Liu CH Zeng SJ Li QW Wang LS Li 2006 Podocyte lesions in patients with obesity-related glomerulopathy Am J Kidney Dis 48 772 9
68. M Sharma R Sharma AS Greene ET McCarthy VJ Savin 1998 Documentation of angiotensin II receptors in glomerular epithelial cells Am J Physiol 274 F623 7
69. TB Huber J Gloy A Henger P Schollmeyer R Greger P Mundel 1998 Catecholamines modulate podocyte function J Am Soc Nephrol 9 335 45
70. J Ortmann K Amann RP Brandes M Kretzler K Munter N Parekh 2004 Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition Hypertension 44 974 81
71. B Lewko N Endlich W Kriz J Stepinski K Endlich 2004 C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress Kidney Int 66 1001 8
72. M Nagase K Ando T Katafuchi A Kato S Hirose T Fujita 1997 Role of natriuretic peptide receptor type C in Dahl salt-sensitive hypertensive rats Hypertension 30 177 83
73. M Hino M Nagase S Kaname S Shibata T Nagase S Oba 2005 Expression and regulation of adrenomedullin in renal glomerular podocytes. Biochem Biophys Res Commun 330 178 85
74. RV Durvasula AT Petermann K Hiromura M Blonski J Pippin P Mundel 2004 Activation of a local tissue angiotensin system in podocytes by mechanical strain Kidney Int 65 30 9
75. E Yaoita K Kawasaki T Yamamoto I Kihara 1990 Variable expression of desmin in rat glomerular epithelial cells Am J Pathol 136 899 908
76. P Mundel J Reiser A Zuniga Mejia Borja H Pavenstadt GR Davidson W Kriz 1997 Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines Exp Cell Res 236 248 58
77. CC Mann 2005 Public health. Provocative study says obesity may reduce U S life expectancy Science 307 1716 7
78. JS Flier 2004 Obesity wars: molecular progress confronts an expanding epidemic Cell 116 337 50
79. CS Fox MG Larson EP Leip B Culleton PW Wilson D Levy 2004 Predictors of new-onset kidney disease in a community-based population Jama 291 844 50
80. CY Hsu CE McCulloch C Iribarren J Darbinian AS Go 2006 Body mass index and risk for end-stage renal disease Ann Intern Med 144 21 8
81. K Iseki Y Ikemiya K Kinjo T Inoue C Iseki S Takishita 2004 Body mass index and the risk of development of end-stage renal disease in a screened cohort Kidney Int 65 1870 6
82. RP Gelber T Kurth AT Kausz JE Manson JE Buring AS Levey 2005 Association between body mass index and CKD in apparently healthy men Am J Kidney Dis 46 871 80
83. JR Weisinger RL Kempson FL Eldridge RS Swenson 1974 The nephrotic syndrome: a complication of massive obesity Ann Intern Med 81 440 7
84. RD Adelman 2002 Obesity and renal disease Curr Opin Nephrol Hypertens 11 331 5
85. JR Henegar SA Bigler LK Henegar SC Tyagi JE Hall 2001 Functional and structural changes in the kidney in the early stages of obesity J Am Soc Nephrol 12 1211 7
86. M Praga E Morales 2006 Obesity, proteinuria and progression of renal failure Curr Opin Nephrol Hypertens 15 481 6
87. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin 2005 Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement Circulation 112 2735 52
88. KG Alberti P Zimmet J Shaw 2005 The metabolic syndrome - a new worldwide definition Lancet 366 1059 62
89. J Chen P Muntner LL Hamm DW Jones V Batuman V Fonseca 2004 The metabolic syndrome and chronic kidney disease in U.S. adults Ann Intern Med 140 167 74
90. M Kurella JC Lo GM Chertow 2005 Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults J Am Soc Nephrol 16 2134 40
91. H Tanaka Y Shiohira Y Uezu A Higa K Iseki 2006 Metabolic syndrome and chronic kidney disease in Okinawa, Japan Kidney Int 69 369 74
92. T Ninomiya Y Kiyohara M Kubo K Yonemoto Y Tanizaki Y Doi 2006 Metabolic syndrome and CKD in a general Japanese population: the Hisayama Study Am J Kidney Dis 48 383 91
93. ML Tuck J Sowers L Dornfeld G Kledzik M Maxwell 1981 The effect of weight reduction on blood pressure, plasma renin activity, and plasma aldosterone levels in obese patients N Engl J Med 304 930 3
94. S Engeli J Bohnke K Gorzelniak J Janke P Schling M Bader 2005 Weight loss and the renin-angiotensin-aldosterone system Hypertension 45 356 62
95. M Ruano V Silvestre R Castro MC Garcia-Lescun A Rodriguez A Marco 2005 Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis Obes Surg 15 670 6
96. RB de Paula AA da Silva JE Hall 2004 Aldosterone antagonism attenuates obesity-induced hypertension and glomerular hyperfiltration Hypertension 43 41 7
97. M Bochud J Nussberger P Bovet MR Maillard RC Elston F Paccaud 2006 Plasma aldosterone is independently associated with the metabolic syndrome Hypertension 48 239 45
98. K Takaya Y Ogawa J Hiraoka K Hosoda Y Yamori K Nakao 1996 Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat Nat Genet 14 130 1
99. GH Williams 2005 Aldosterone biosynthesis, regulation, and classical mechanism of action Heart Fail Rev 10 7 13
100. TL Goodfriend DA Calhoun 2004 Resistant hypertension, obesity, sleep apnea, and aldosterone: theory and therapy Hypertension 43 518 24
101. GS Hotamisligil NS Shargill BM Spiegelman 1993 Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 87 91
102. I Shimomura T Funahashi M Takahashi K Maeda K Kotani T Nakamura 1996 Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nat Med 2 800 3
103. M Ehrhart-Bornstein V Lamounier-Zepter A Schraven J Langenbach HS Willenberg A Barthel 2003 Human adipocytes secrete mineralocorticoid-releasing factors Proc Natl Acad Sci USA 100 14211 6
104. DM Stocco X Wang Y Jo PR Manna 2005 Multiple signaling pathways regulating steroidogenesis and steroidogenic acute regulatory protein expression: more complicated than we thought Mol Endocrinol 19 2647 59
105. TL Goodfriend DL Ball BM Egan WB Campbell K Nithipatikom 2004 Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion Hypertension 43 358 63
106. RJ Hene P Boer HA Koomans EJ Mees 1982 Plasma aldosterone concentrations in chronic renal disease Kidney Int 21 98 101
107. JC Verhave HL Hillege JG Burgerhof WM Janssen RT Gansevoort GJ Navis 2004 Sodium intake affects urinary albumin excretion especially in overweight subjects J Intern Med 256 324 30
108. E Ritz R Dikow C Morath V Schwenger 2006 Salt-a potential "uremic toxin?" Blood Purif 24 63 6
109. C Kitiyakara T Chabrashvili Y Chen J Blau A Karber S Aslam 2003 Salt intake, oxidative stress, and renal expression of NADPH oxidase and superoxide dismutase J Am Soc Nephrol 14 2775 82
110. M Farjah BP Roxas DL Geenen RS Danziger 2003 Dietary salt regulates renal SGK1 abundance: relevance to salt sensitivity in the Dahl rat Hypertension 41 874 8